Pacific Biosciences: Q4 Earnings Insights

Pacific Biosciences PACB reported its Q4 earnings results on Thursday, February 15, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.

Pacific Biosciences beat estimated earnings by 3.57%, reporting an EPS of $-0.27 versus an estimate of $-0.28.

Revenue was up $31.00 million from the same period last year.

Last quarter the company beat on EPS by $0.05 which was followed by a 13.08% drop in the share price the next day.

Here's a look at Pacific Biosciences's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	-0.32	-0.32	-0.33	-0.36
EPS Actual	-0.27	-0.26	-0.31	-0.35
Revenue Estimate	48.76M	40.30M	34.38M	26.24M
Revenue Actual	55.69M	47.57M	38.90M	27.35M

To track all earnings releases for Pacific Biosciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar